| abstract |
The present invention relates to heteroaryl derivatives that are modulators of CFTR, in particular modulators of ATP-binding cassette ("ABC") transporters or fragments thereof, including cystic fibrosis transmembrane conductance regulator ("CFTR"), its Compositions and methods of use thereof. The invention also relates to methods of using such modulators to treat ABC transporter mediated diseases. |